SPL starpharma holdings limited

Ann: Shareholder Newsletter, page-4

  1. 4,027 Posts.
    lightbulb Created with Sketch. 991
    Interestingly, this newsletter contains the first hint/trace/acknowledgment that I’ve seen by Starpharma, that the first 2 years of AstraZeneca in the clinic with AZD0466 was pretty much a dud after starting the trial up against solid cancers. AZ essentially started Phase 1 again last year trialling against other cancer types.

    Newsletter today: “The leukemia trial replaces the first-in-human study in solid cancers, following AstraZeneca’s decision to focus initial development activities on haematological cancers…”

    TWO FRIGGING YEARS
    Last edited by sarge17: 03/06/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.3¢
Change
0.002(2.20%)
Mkt cap ! $38.89M
Open High Low Value Volume
9.1¢ 9.3¢ 9.1¢ $14.15K 154.5K

Buyers (Bids)

No. Vol. Price($)
2 350000 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 110634 2
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.